[HTML][HTML] Pathogenic mechanism and multi-omics analysis of oral manifestations in COVID-19

M Hao, D Wang, Q Xia, S Kan, L Chang, H Liu… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease that seriously
threatens human life. The clinical manifestations of severe COVID-19 include acute …

[HTML][HTML] Is COVID-19 severity associated with telomere length? A systematic review and meta-analysis

M Haridoss, L Ayyasamy, BS Bagepally - Virus Genes, 2023 - Springer
Telomere shortening, a marker of cellular aging, has been linked to hospitalization and the
severity of COVID-19. In this systematic review and meta-analysis, the mean difference in …

[HTML][HTML] Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals

S Mahajan, V Kode, K Bhojak, C Karunakaran… - Scientific Reports, 2021 - nature.com
The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients
with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine …

Investigating biomarkers for COVID-19 morbidity and mortality

FM Ceci, G Ferraguti, M Lucarelli… - Current Topics in …, 2023 - ingentaconnect.com
Background and Objectives: This retrospective study aims to disclose further early
parameters of COVID-19 morbidity and mortality. Methods: Three hundred and eighty-two …

[HTML][HTML] Characteristics of the severe acute respiratory syndrome coronavirus 2 omicron BA. 2 subvariant in Jilin, China from March to May 2022

H Liu, S Wang, S Yang, SX Luo, J Jie, S Hua… - Journal of …, 2023 - degruyter.com
Abstract Background and Objectives In the midst of the pandemic, new coronavirus mutants
continue to emerge; the most relevant variant worldwide is omicron. Here, patients who …

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19

R Wang, Y Sun, BH Kuang, X Yan, J Lei… - Emerging Microbes & …, 2023 - Taylor & Francis
Replicating SARS-CoV-2 has been shown to degrade HLA class I on target cells to evade
the cytotoxic T-cell (CTL) response. HLA-I downregulation can be sensed by NK cells to …

In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral …

P Sen, H Kaur - Human Gene, 2023 - Elsevier
COVID-19 is a severe respiratory disease caused by SARS-CoV-2, a novel human
coronavirus. Patients infected with SARS-CoV-2 exhibit heterogeneous symptoms that pose …

Effects of Epitranscriptomic RNA Modifications on the Catalytic Activity of the SARS‐CoV‐2 Replication Complex

A Apostle, Y Yin, K Chillar, AMDN Eriyagama… - …, 2023 - Wiley Online Library
SARS‐CoV‐2 causes individualized symptoms. Many reasons have been given. We
propose that an individual's epitranscriptomic system could be responsible as well. The viral …

Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study

APJ Rabe, WJ Loke, RN Kalyani, R Tummala… - BMJ open, 2023 - bmjopen.bmj.com
Objectives Determine the prevaccination healthcare impact of COVID-19 in patients with
systemic lupus erythematosus (SLE) in England. Design Retrospective cohort study of adult …

[HTML][HTML] Lycorine derivative effectively inhibits the replication of coronaviruses both in vitro and in vivo

L Shen, J Zhao, Y Xia, J Lu, J Sun, J Tang, H Xing… - hLife, 2024 - Elsevier
The established and ongoing prevalence of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) and seasonal human coronaviruses (HCoV) like HCoV-OC43, HCoV …